NARP syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:644OMIM:551500E88.8
Who is this for?
Show terms as
3Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

NARP syndrome (Neuropathy, Ataxia, and Retinitis Pigmentosa) is a rare mitochondrial disorder caused by pathogenic variants in the MT-ATP6 gene, which encodes a subunit of mitochondrial ATP synthase (complex V). The condition is characterized by a triad of sensory or sensorimotor neuropathy, cerebellar ataxia, and retinitis pigmentosa (progressive degeneration of the retina). NARP syndrome is part of a clinical spectrum that also includes maternally inherited Leigh syndrome (MILS), with the severity largely determined by the heteroplasmy level of the mitochondrial DNA mutation, most commonly the m.8993T>G or m.8993T>C variant. When the mutation load is typically between 70% and 90%, the NARP phenotype predominates, whereas higher mutation loads (above 90%) are more commonly associated with the more severe Leigh syndrome. The disease primarily affects the nervous system and the eyes. Additional clinical features may include learning difficulties, developmental delay, seizures, dementia, proximal muscle weakness, and hearing loss. Cardiac conduction defects and short stature have also been reported in some patients. Symptoms typically emerge in childhood or young adulthood, though the age of onset and severity can vary considerably even within the same family due to differences in mitochondrial mutation load across tissues. There is currently no cure for NARP syndrome. Treatment is supportive and symptomatic, focusing on management of neurological symptoms, seizure control with appropriate anticonvulsants, physical and occupational therapy for ataxia and neuropathy, and ophthalmological monitoring for retinitis pigmentosa. Nutritional supplementation with coenzyme Q10, B vitamins, and other mitochondrial cofactors has been tried, though evidence for efficacy remains limited. Genetic counseling is important for affected families, particularly regarding the complexities of mitochondrial inheritance and the unpredictable nature of heteroplasmy transmission from mother to offspring.

Also known as:

Clinical phenotype terms— hover any for plain English:

Constriction of peripheral visual fieldHP:0001133Retinal arteriolar tortuosityHP:0001136Myoclonic spasmsHP:0003739
Inheritance

Mitochondrial

Passed from mother to child through the energy-producing parts of the cell

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for NARP syndrome.

View clinical trials →

No actively recruiting trials found for NARP syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the NARP syndrome community →

Specialists

3 foundView all specialists →
MM
Michio Hirano, MD
NEW YORK, NY
Specialist
PI on 10 active trials
TD
Thomas Klopstock, Prof. Dr.
Specialist
PI on 3 active trials
MD
Michelangelo Mancuso, Prof. Dr.
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to NARP syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open NARP syndromeForum →

No community posts yet. Be the first to share your experience with NARP syndrome.

Start the conversation →

Latest news about NARP syndrome

No recent news articles for NARP syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about NARP syndrome

What is NARP syndrome?

NARP syndrome (Neuropathy, Ataxia, and Retinitis Pigmentosa) is a rare mitochondrial disorder caused by pathogenic variants in the MT-ATP6 gene, which encodes a subunit of mitochondrial ATP synthase (complex V). The condition is characterized by a triad of sensory or sensorimotor neuropathy, cerebellar ataxia, and retinitis pigmentosa (progressive degeneration of the retina). NARP syndrome is part of a clinical spectrum that also includes maternally inherited Leigh syndrome (MILS), with the severity largely determined by the heteroplasmy level of the mitochondrial DNA mutation, most commonly t

How is NARP syndrome inherited?

NARP syndrome follows a mitochondrial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

Which specialists treat NARP syndrome?

3 specialists and care centers treating NARP syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.